SILENCE THERAP. SP.ADR/1 Financial Flexibility Index
SILENCE THERAP. SP.ADR/1 financial flexibility index. SILENCE THERAP. SP.ADR/1 (XRP2) has a Financial Flexibility Index of -0.25x as of December 2025. Free cash flow of €-17.29 Million (operating CF €-17.29 Million minus capex €0.00) represents 0% of total liabilities (€69.14 Million). See SILENCE THERAP. SP.ADR/1 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SILENCE THERAP. SP.ADR/1 (2021–2025)
Financial flexibility index of SILENCE THERAP. SP.ADR/1 from 2021 to 2025. Historical Financial Flexibility Index trend for SILENCE THERAP. SP.ADR/1 across 5 annual periods. Explore SILENCE THERAP. SP.ADR/1 debt service capacity to assess how comfortably operating cash covers total debt obligations.
SILENCE THERAP. SP.ADR/1 Financial Flexibility Index by Year (2021–2025)
SILENCE THERAP. SP.ADR/1 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for SILENCE THERAP. SP.ADR/1. For the full cash flow conversion analysis, see cash efficiency ratio of SILENCE THERAP. SP.ADR/1.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.90x | €-62.22 Million | €-62.27 Million | €69.14 Million | ▲ +8.4% |
| 2024 | -0.98x | €-67.43 Million | €-67.64 Million | €68.61 Million | ▼ -93.9% |
| 2023 | -0.51x | €-49.41 Million | €-49.46 Million | €97.45 Million | ▲ +7.2% |
| 2022 | -0.55x | €-56.50 Million | €-57.04 Million | €103.38 Million | ▼ -688.6% |
| 2021 | 0.09x | €10.99 Million | €9.19 Million | €118.32 Million | — |